Early Formulation Feasibility
Frame an initial formulation hypothesis and a focused study to determine whether a credible development route exists.
Jinbosen Bio works with biotechnology companies, pharmaceutical teams and translational researchers on programmes where formulation composition, nanoscale structure and biological barriers need to be understood together.
The first question may concern feasibility, candidate selection, a difficult-to-deliver payload, unexplained formulation behaviour or the suitability of a technology platform.
Frame an initial formulation hypothesis and a focused study to determine whether a credible development route exists.
Evaluate delivery barriers and formulation implications for nucleic acids, peptides, proteins and selected challenging molecules.
Investigate how composition, process and nanoscale attributes may influence stability, payload behaviour and in vitro performance.
Assess whether a lipid, vesicle or hybrid formulation platform is technically aligned with a payload and product concept.
Identify critical quality attributes, process sensitivities, reproducibility risks and evidence needed for further development.
Combine complementary scientific and development capabilities around a defined programme, work plan and decision pathway.
The appropriate model depends on the current evidence, the technical question and how responsibilities should be shared. An initial non-confidential discussion can identify a practical starting point.
A bounded first project with a defined question, study plan and decision point.
A broader programme spanning formulation screening, characterisation, in vitro evaluation or process development.
A jointly planned programme with aligned technical objectives, workstreams and stage gates.
Evaluation or integration of complementary formulation, delivery or analytical capabilities.
Early technical dialogue about knowledge transfer, process requirements and the evidence needed to evaluate fit.
A staged route in which scope expands only when results support the next technical question.
Good technical collaboration connects the scientific problem to a formulation implication, the development work needed to investigate it and the decision the partner must make.
A concise, non-confidential summary of the molecule, intended route, current evidence and desired decision is enough to begin a scoping conversation.